Navigation Links
American Chemical Society's Weekly PressPac -- Sept. 19, 2007
Date:9/24/2007

s, but new treatments in the pipeline
Chemical & Engineering News

An arsenal of promising new medications, vaccines, and diagnostic tests are moving toward the global battlefield that pits medicine against drug-resistant tuberculosis (TB), which is claiming a terrible toll, particularly in HIV-infected individuals, according to an article [http://pubs.acs.org/cen/coverstory/85/8539cover.html] scheduled for the Sept. 24 issue of Chemical & Engineering News, ACS weekly newsmagazine.

In the cover feature, C&EN senior correspondent Ann Thayer and assistant editor Carmen Drahl describe far-ranging efforts underway to develop new TB diagnostic tests and treatments. For years, conventional treatments for TB had slowed the spread of the disease, but the emergence of new drug-resistant strains has reduced the effectiveness of those medications. Researchers are developing more accurate diagnostic tests, new drugs to fight multidrug resistant strains, and ones that are more compatible with individuals who are undergoing treatment for HIV. Scientists are also developing more effective vaccines, including those that might show promise for both preventing and treating the disease, Thayer notes.

In the past five years or so, the TB drug pipeline has shifted from nearly empty to having about 30 compounds under investigation; several are in early clinical testing, Thayer writes.

ARTICLE #5 EMBARGOED FOR 9 A.M., EASTERN TIME, Sept. 24, 2007
Taking Down TB

This story will be available on Sept. 24 at:
http://pubs.acs.org/cen/coverstory/85/8539cover.html

FOR ADVANCE INFORMATION, CONTACT:
Michael Bernstein
ACS News Service
Phone: 202-872-6042
Fax: 202-847-4370
E-mail: m_bernstein@acs.org


FOR
'/>"/>

Contact: Michael Woods
m_woods@acs.org
202-872-4400
American Chemical Society
Source:Eurekalert

Page: 1 2 3 4 5 6 7 8

Related biology news :

1. First North American Encapsulated Islet Transplant without Long-term Immune Suppression into a Patient with Type 1 Diabetes
2. Health costs soar as 60 million Americans classed as obese
3. Discovery of an American salamander where it shouldnt be: Korea
4. DNA traces evolution of extinct sabertooths and the American cheetah-like cat
5. North & South American researchers find architectural abnormalities in T. cruzi ribosome
6. T-rays: New imaging technology spotlighted by American Chemical Society
7. New peptide antibiotic isolated from American oyster
8. Computers to save unique type of American red squirrel
9. Alcoholism, smoking and genetics among Plains American Indians
10. Gene variation increases SIDS risk in African Americans
11. Americans support free access to research

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...cientists from the Marine Biogeochemistry and Geol...Laboratory (NRL) organized and led a team of unive...ition to initiate methane hydrate exploration in t...n of sediment contribution to Arctic climate chang... Sea as a research platform, three cross-shelf tra...
(Date:11/20/2009)...ia possess an ingenious mechanism for preventing o.... This is the new finding of a team of biologists ...s research institute in Flanders, Belgium, connect...ts made this discovery by modifying the DNA of the... of this model organism, they have uncovered the e...
(Date:11/20/2009)...earchers report that a class of heart medications ...l, effect on the heart, depending on their molecul...ournal Circulation Research , found that beta-blo...rs on the heart muscle offer the most benefit to c...beta-receptors can actually undermine the structur...
Breaking Biology News(10 mins):International expedition investigates climate change, alternative fuels in Arctic 2Biologists discover bacterial defense mechanism against aggressive oxygen 2Carvedilol shown to have unique characteristics among beta blockers 2The CJ Foundation for SIDS Announces SLEEP IN SAFETY GROW IN STYLE Initiative 48530 1The CJ Foundation for SIDS Announces SLEEP IN SAFETY GROW IN STYLE Initiative 48530 2Morning Sickness Drug Gets Green Light in Study 48525 1Morning Sickness Drug Gets Green Light in Study 48525 2Morning Sickness Drug Gets Green Light in Study 48525 3Jury Awards 245 45 Million to Bronx Man With A Misdiagnosed Staph Infection New York Medical Malpractice Attorney David Perecman Comments 48521 1Jury Awards 245 45 Million to Bronx Man With A Misdiagnosed Staph Infection New York Medical Malpractice Attorney David Perecman Comments 48521 2Jury Awards 245 45 Million to Bronx Man With A Misdiagnosed Staph Infection New York Medical Malpractice Attorney David Perecman Comments 48521 3
...State University,s Center for Advanced Power Syste...n that seeks to transform the nation,s electric po...Alliance, a group of 69 leading companies and acad...nowledge and innovation in an effort to increase t...wer grid. , "CAPS looks forward to contributing t...
... York have discovered a ,Chemical Equator, that di...from the largely uncontaminated atmosphere of the ...rsity,s Department of Chemistry found evidence for... in cloudless skies in the Western Pacific. Their ... and meteorological boundaries between the two air...
...ists are to investigate the biological causes of t...imer,s, thanks to a prestigious 1.9 million senior...l. , Frontotemporal lobar degeneration (FTLD) is ...emporal lobes of the brain and are characterised b...the memory loss associated with Alzheimer,s diseas...
Other Biology News:FSU joins coalition working to improve nation's power grid 2'Chemical equator' discovery will aid pollution mapping 2£2 million study to reveal workings of dementia genes 2
(Date:11/20/2009)...Nov. 20 Novavax, Inc. (N...an underwritten public offering of 6,800,000 share...$3.30 per share. The approximately $21 million of...scounts and commissions, will be used for preclini...accines, internal research and development program...
(Date:11/20/2009)...20 Cell Therapeutics, In...at the Ninth Circuit Court of Appeals reversed a U... be allowed to pursue all of its claims against Th...t Court for trial. CTI filed a complaint against ...ment consultant for CTI,s product TRISENOX, in 200...
(Date:11/20/2009)...TLER TOLEDO recently announced that Dr. Dominique ...ole of Process Analytical Technology (PAT) in Gree...er 1, 2009. , (PRWEB) Nov...Analytical Technology (PAT) in Green Chemistry and... Analytical Technology (PAT) case studies will be ...
(Date:11/19/2009)... Danish Prince Joachim inaugurated...ant in Kalundborg, Denmark, on Wednesday, November...largest 2nd generation ethanol demonstration biore...in the plant,s innovative process for converting s... the first to market with commercial enzymes for c...
Breaking Biology Technology:Novavax Prices Public Offering of Common Stock 2Cell Therapeutics Wins Federal Appeal to Pursue $22.8 Million Claim Against The Lash Group 2Process Analytical Technology (PAT) in Green Chemistry and Green Engineering 2DONG Energy and Inbicon Inaugurate One of the World's Largest Demo Plants for 2nd Generation Biofuel 2
...., Aug. 27 Globus Medical, Inc., the largest,priv...d, today announced,record revenue for the quarter ...s of $30.2 million for the second quarter -- an in...n the same quarter a year ago. The,announcement fo...ancing to,fund Globus, continued rapid growth. "T...
...srael, August 27 Notice is hereby,given that the ... of the,Shareholders of Rosetta Genomics Ltd. (NAS... be held at the offices of Yigal Arnon & Co., Azri...ael on Monday, September 24,2007, at 11:00 a.m. (I...rove the appointment of Kost, Forer, Gabbay & Kasi...
...IANGLE PARK, N.C., Aug. 27 NovaQuest has,made a s...c., a,clinical-stage biopharmaceutical company spe... was part of a private placement of C$26 million,(...t week,s The investment by NovaQuest, the strategi...ps TOPIGEN accelerate its Phase II,lead-product cl...
Other Biology Technology:Globus Medical Announces Record 2nd Quarter 2007 Results 2Rosetta Genomics Announces Annual General Meeting of Shareholders to be Held on September 24, 2007 2NovaQuest Advances 'Virtual Development' Model With Strategic Investment in TOPIGEN Pharmaceuticals 2
Rabbit Anti-Human Tankyrase 2 (TNKL (TNKS2) Polyclonal Antibody, Unconjugated from Lifespan Biosciences
Anti-VAMP-2 (Vesicle-Associated Membrane Protein 2, Synaptobrevin 2) Polyclonal Antibody, Unconjugated from CHEMICON
...nrelated proteins both of which function in tumor ...p53-dependent manner. p14^ARF^ binds to mdm2 and p...red for mdm2 modification and concurrent p53 stabi...diated by the exon 1Beta-encoded N-terminal domain...
Human Exodus-2 from MBL International
Biology Products: